Caso contributivo
Infezioni ricorrenti nel lattante: spia di un problema più complesso?
Recurrent infections in a newborn: are there a sign of a more complex problem?
Carmelina Calitri, Federica Mignone, Chiara Bertaina, Clara Gabiano, Carlo Scolfaro
SCDU Immuno-Reumatologia e Malattie Infettive, Dipartimento di Scienze pediatriche e dell’Adolescenza, Università di Torino
Dicembre 2010
Contenuto HTML non disponibile.
Classificazione MeSH
Bibliografia
1. WHO, United Nations Children’s Fund, UNAIDS. AIDS epidemic update. December 2009.
2. Istituto Superiore di Sanità - Centro Operativo AIDS. L’epidemiologia dell’HIV/AIDS in Italia. Dicembre 2009. Disponibile su: http://www.ministerosalute.it/dettaglio/pdPrimoPianoNew.jsp?id=257⊂=1〈=it
3. Volmink J, Siegfried N, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. The Cochrane Library 2009.
4. Perinatal HIV Guidelines Working Group.Public Health Service Task Force. Recommendations for Use of AntiretroviralDrugs in Pregnant HIV-Infected Women forMaternal Health andInterventions to Reduce Perinatal HIV Transmission in the United States. April 29, 2009; pp 1-90
5. RED BOOK 2009: sezione 3, pp: 380-400
6. MMWR recommendations and reports. 1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age. Sept 30, 1994 / 43(RR-12); 1-10. Disponibile su: http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm
7. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. November 3, 2008;1-139.
8. MMWR. Recommendations and reports. Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children. September 04, 2009 / 58(RR11);1-166.